Eric Chen Quin Lam - Concepedia

Author

Eric Chen Quin Lam

Also Known As

E Lam, E. C. Q. Lam, E. Lam, E.C.Q. Lam, Enrique Tantalean Lam, Eric C. Q. Lam, Eric Chen Quin Lam, Eric Lam, Eugene Lam, Lam, E.

Publications

342

Citations

H-Index

Concepts

All Affiliations

Eric Chen Quin Lam is an author at Eli Lilly (United States).

Eric Chen Quin Lam

Publications

265

Citations

H-Index

Page 1

	Year	Citations
Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies Helle Linnebjerg, Eric Chen Quin Lam, Mary Seger, Diabetes Care	2015	95
Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects Robert R. Henry, Sunder Mudaliar, Theodore P. Ciaraldi, Diabetes Care	2014	58
Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance Dominic S. Ng, Chunhui Xie, Graham F. Maguire, Journal of Biological Chemistry	2004	44
Duration of action of two insulin glargine products, <scp>LY2963016</scp> insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus Helle Linnebjerg, Eric Chen Quin Lam, Xin Zhang, Diabetes Obesity and Metabolism	2016	30
Reduced peripheral activity leading to hepato‐preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes Sunder Mudaliar, Robert R. Henry, Theodore P. Ciaraldi, Diabetes Obesity and Metabolism	2016	19
LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels Xin Zhang, Eric Chen Quin Lam, Mary Seger, Clinical Pharmacology in Drug Development	2017	19

Page 1